VectorB2B is one of the co-promoters of the Bio-Hub Agenda – a National R&D Platform for Production, Commercialization and Distribution of Innovative Biopharmaceuticals – together with LxBio – Pharmaceuticals, TechnoPhage and Faculty of Pharmacy of the University of Lisbon.
On April 4th, 2023, the leader LxBio – Pharmaceuticals announced a new phase of the Bio-Hub mobilizing agenda through the launch of the consortium website which will allow for quick and accessible dissemination of the project.
Bio-Hub Agenda emerges as one of the first running agendas with the goal of developing and producing new biopharmaceuticals in Portugal aiming for international markets.
The Consortium has an incentive of €19M out of a total investment of €35M, which intends to see implemented by the end of 2025.
Learn more about it in the links below
#PRR #construirofuturo #vectorb2b #biopharmaceuticals